A detailed history of Advisor Net Financial, Inc transactions in Invitae Corp stock. As of the latest transaction made, Advisor Net Financial, Inc holds 50,000 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,000
Previous 20,000 150.0%
Holding current value
$0
Previous $12,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$0.01 - $0.61 $300 - $18,300
30,000 Added 150.0%
50,000 $0
Q3 2023

Oct 12, 2023

BUY
$0.6 - $1.53 $6,000 - $15,300
10,000 Added 100.0%
20,000 $12,000
Q3 2022

Oct 04, 2022

BUY
$1.9 - $8.63 $7,197 - $32,690
3,788 Added 60.98%
10,000 $25,000
Q2 2022

Jul 07, 2022

BUY
$2.13 - $9.01 $4,711 - $19,930
2,212 Added 55.3%
6,212 $15,000
Q1 2022

Apr 14, 2022

BUY
$6.28 - $15.59 $6,280 - $15,590
1,000 Added 33.33%
4,000 $32,000
Q4 2021

Jan 19, 2022

BUY
$14.7 - $28.67 $14,185 - $27,666
965 Added 47.42%
3,000 $46,000
Q1 2021

Apr 14, 2021

BUY
$33.06 - $56.93 $59,508 - $102,474
1,800 Added 765.96%
2,035 $78,000
Q4 2020

Feb 04, 2021

BUY
$39.09 - $57.4 $1,368 - $2,009
35 Added 17.5%
235 $10,000
Q3 2020

Nov 06, 2020

SELL
$28.43 - $44.67 $3,553 - $5,583
-125 Reduced 38.46%
200 $9,000
Q2 2020

Aug 26, 2020

SELL
$11.71 - $30.29 $2,342 - $6,058
-200 Reduced 38.1%
325 $10,000
Q1 2020

May 14, 2020

BUY
$7.64 - $27.5 $1,528 - $5,500
200 Added 61.54%
525 $7,000
Q4 2019

Feb 12, 2020

BUY
$15.02 - $20.57 $4,881 - $6,685
325 New
325 $5,000
Q1 2018

May 08, 2018

SELL
$4.69 - $10.05 $7,400 - $15,858
-1,578 Closed
0 $0
Q4 2017

Feb 27, 2018

BUY
$7.86 - $9.99 $12,403 - $15,764
1,578
1,578 $14,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.